Wave Life Sciences (WVE) Prepaid Assets (2014 - 2026)
Wave Life Sciences' (WVE) quarterly Prepaid Assets came in at $12.1 million in Q2 2026, up 79.36% YoY from $6.8 million in Q2 2025, and down 8.35% on a QoQ basis from $13.2 million in Q1 2026.
Analysis
Wave Life Sciences (WVE) Prepaid Assets (2014 - 2026) Analysis & Trends
Wave Life Sciences (WVE) has 13 years of Prepaid Assets data on file, last reported at $12.1 million in Q2 2026.
- Quarterly Prepaid Assets rose 79.36% year-over-year to $12.1 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $12.1 million (up 79.36% YoY) and the FY2025 annual result came in at $8.4 million, down 12.04% from the prior year.
- Prepaid Assets retreated to $12.1 million in Q2 2026, from $13.2 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $13.2 million in Q1 2026 to a low of $6.6 million in Q2 2022.
- A 5-year average of $9.1 million and a median of $8.7 million in 2023 frame the typical range for Prepaid Assets.
- Annual changes were most pronounced in 2025 — Prepaid Assets tumbled 44.36% — and 2026, when it soared 79.36%.
- Tracing WVE's Prepaid Assets over 5 years: stood at $7.9 million in 2022, then grew by 24.96% to $9.9 million in 2023, then slipped by 3.71% to $9.5 million in 2024, then fell by 12.04% to $8.4 million in 2025, then soared by 44.38% to $12.1 million in 2026.
- The last three Prepaid Assets figures came in at $12.1 million (Q2 2026), $13.2 million (Q1 2026), and $8.4 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Wave Life Sciences | 994.54 Mn | 626.53 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12.12 Mn |
| Mar 31, 2026 | 13.23 Mn |
| Dec 31, 2025 | 8.40 Mn |
| Sep 30, 2025 | 6.65 Mn |
| Jun 30, 2025 | 6.76 Mn |
| Mar 31, 2025 | 8.06 Mn |
| Dec 31, 2024 | 9.54 Mn |
| Sep 30, 2024 | 10.57 Mn |
| Jun 30, 2024 | 12.15 Mn |
| Mar 31, 2024 | 11.14 Mn |
| Dec 31, 2023 | 9.91 Mn |
| Sep 30, 2023 | 7.51 Mn |
| Jun 30, 2023 | 9.01 Mn |
| Mar 31, 2023 | 9.23 Mn |
| Dec 31, 2022 | 7.93 Mn |
| Sep 30, 2022 | 7.42 Mn |
| Jun 30, 2022 | 6.56 Mn |
| Mar 31, 2022 | 6.94 Mn |
| Dec 31, 2021 | 6.58 Mn |
| Sep 30, 2021 | 7.63 Mn |